Pacer Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRWD
AC
SCM
VPM
VCM
Pacer Advisors's IRWD Position: Q1 2026 in Review
Pacer Advisors opened a new position in Ironwood Pharmaceuticals (IRWD) in Q1 2026: 1,134,512 shares worth $3.98M. The stake represents 0.01% of the portfolio and ranks #680 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in IRWD as recently as Q1 2025.
Pacer Advisors first reported a position in IRWD in Q4 2017 and has held it in 16 quarters since. The position peaked at $62.8M in Q1 2024. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.
- Pacer Advisors held 1,134,512 shares of Ironwood Pharmaceuticals worth $3.98M as of Q1 2026.
- Ironwood Pharmaceuticals was a new Pacer Advisors position in Q1 2026.
- Ironwood Pharmaceuticals made up 0.01% of Pacer Advisors's portfolio in Q1 2026, its #680 holding.
- Pacer Advisors first reported a position in Ironwood Pharmaceuticals in Q4 2017 and has held it in 16 quarters since.
- Pacer Advisors's Ironwood Pharmaceuticals position peaked at $62.8M in Q1 2024.
- 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.
Based on Pacer Advisors's 13F filing for Q1 2026, filed 6 May 2026.